Navigation Links
Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial
Date:5/7/2011

a Phase 2 clinical trial for serious community-acquired bacterial pneumonia or CABP," said David Oldach, M.D., vice president of clinical research at Cempra.  "This drug could be the first macrolide since azithromycin to offer both oral and intravenous forms of administration.  This will enable in-hospital treatment of seriously ill patients and will make possible IV to oral step-down therapy, shortening hospital stays.  We are excited about this compound because of its broad spectrum of activity including macrolide-resistant strains, its greater potency than existing macrolides and its dosing flexibility.  We look forward to advancing both IV and oral forms into the next stages of clinical development."

Solithromycin (CEM-101)

Solithromycin has shown a broad spectrum of activity and high potency against respiratory and other serious pathogens in in vitro and in vivo studies.  In vitro data from two studies presented at the conference showed that solithromycin exhibited high potency against European strains associated with CABP and exhibited stronger activity against Haemophilus influenzae compared to telithromycin.  

Biedenbach et al. (Abst. P1136) evaluated the activity of solithromycin against more than 6,300 isolates collected from 18 European countries in 2010.  Activity was tested against pathogens associated with CABP and acute bacterial skin and skin structure infections (ABSSSI), such as Staphylococcus aureus (including MRSA), coagulase-negative staphylococci, enterococci, Streptococcus pneumoniae, Streptococcus viridians, beta-haemolytic streptococci, H. influenzae and Moraxella catarrhalis.  Solithromycin exhibited greater potency than telithromycin and clindamycin against these contemporary
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies
3. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
4. Reportlinker Adds Global Intravenous (IV) Iron Drugs Industry
5. Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
6. Reportlinker Adds Intravenous Equipment - A World Market Intelligence Report
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial
9. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
10. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
11. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... VIEW, Calif. , April 30, 2015  IRIDEX ... will release its first quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:4/30/2015)... -- Thoratec Corporation (NASDAQ: THOR ), a world leader ... restore failing hearts, said today it will participate in ... on Thursday, May 14. D. Keith ... an update on the company, beginning at 10:40 a.m., ... The presentation will be available through the conference ...
(Date:4/30/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) ... financial results after the market closes on Thursday, May ... will be held on Thursday, May 7, 2015, at ... To participate in the call, please dial 877-303-1298 ... rebroadcast of the teleconference will be available for one ...
Breaking Medicine Technology:IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2
... Pharmacy, the nation,s largest, privately owned specialty pharmacy, announced today ... Great Award. "The award is made in ... concept, entrepreneurialism, leadership, work ethic and products have melded in ... the past year," said Stephen Rapundalo, Ph.D., President and CEO ...
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that ... notes. The Company intends to use the ... of the outstanding borrowings under its credit facility and for ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities Inc. ...
Cached Medicine Technology:Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 2Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 3Zimmer Holdings, Inc. Announces Offering of Senior Notes 2
(Date:5/2/2015)... As one of only 30 Illinois ... and Health Achievement and Recognition Program (SHARP) certification, ... by the Illinois Department of Labor to host this ... SHARP certification by the Occupational Safety and Health Administration’s ... continued to meet or exceed all of the necessary ...
(Date:5/2/2015)... 2015 ProText Kinetic 2 is a set ... Cut Pro X. ProText Kinetic 2 features 40 ... Cut Pro X . Easily create interactive text videos ... Studios' ProText Kinetic 2. , Using ProText Kinetic is as ... ProText Kinetic presets in the FCPX timeline. Playback the ...
(Date:5/2/2015)... On Tuesday April 7th, the patient care ... celebrate improvements in patient care. In 2014 the hospital, ... zero acquired ventilator associated infections, zero central line associated ... also recently named a Top Performer by the Joint ... the teamwork of staff from all departments involved in ...
(Date:5/2/2015)... 2015 With the success that Veatch Dental ... to welcome Neida Miranda and Alex Shields to the team. ... over 41 years of combined experience working with dentists to ... dental field for 8 years. She was certified as ... Customer service, positive attitude and showing the importance of oral ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious ... its flagship nutritional supplement, Liquid BioCell™ Life, and the ... new logo, new packaging, new products, and new messaging. ... identify and promote programs that serve as examples of ... Jusuru International for their outstanding accomplishments and contributions to ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
... Oliver Sacks,neurologist, Columbia University professor and New York ... in Awakenings, will share,inspiring stories about the healing ... trauma from his latest work: Musicophilia - Tales ... songwriter Marc Black,will perform, with the Marc Black ...
... MAIDS(R) provides tips to relieve stress, a common cause of heart ... ... color that makes us think,of love and Valentine,s Day. This February, which also ... your most,important organ, your heart. A healthy heart can be attained in a ...
... SHENZHEN, China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- China Display,Technologies, ... "the,Company"), a leading manufacturer of optoelectronic products, specializing,in ... for LCD displays in,China, today announced its Vice ... Officer, Mr. Kam Ming Yip will present at ...
... (NYSE: BSX ) today announced that it has ... businesses to Avista Capital,Partners for $425 million in cash. ... 2007., The Company expects to record an after-tax ... 2008 in connection with the,transaction., "The sale of ...
... have solved a longstanding mystery about how flexing muscles ... to perform, according to a study published Feb. 15 ... new ways to treat conditions that involve poor circulation ... 10 million Americans and leads to amputation in the ...
... Feb. 14 Officials at,Southern Research Institute today ... with GlaxoSmithKline (GSK), has been named Vice,President of ... ), "We are very pleased that ... very,successful drug discovery research program," said John A. ...
Cached Medicine News:Health News:Dr. Oliver Sacks, NYT Bestselling Author, to Inspire and Marc Black, Award-winning Musician, to Perform at National Aphasia Association Benefit on April 1, NYC 2Health News:Healthy Heart, Healthy Home 2Health News:China Display Technologies, Inc. to Present at Roth Conference 2Health News:China Display Technologies, Inc. to Present at Roth Conference 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 4Health News:Researchers discover new way to reverse poor circulation and heal wounds 2Health News:Researchers discover new way to reverse poor circulation and heal wounds 3Health News:Researchers discover new way to reverse poor circulation and heal wounds 4Health News:Southern Research Institute Names Blaine Knight Vice President of Drug Discovery 2
... NEW Vibratome 3000 Plus Sectioning System provides ... fixed, animal, or plant tissues. The ... allows sectioning without freezing or embedding. ... morphology, the destruction of enzyme activities, and ...
Replacement bulb for Vibratome light system....
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
This is a perfect tool for retrieving free floating sections from the Vibratome bath....
Medicine Products: